Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Unitary patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2021 015 571.9 |
96 | EP file number | EAKZ | 21 76 6393.9 |
86 | WO file number | WAKZ | PCT/EP2021/072486 |
97 | EP publication number | EPN | 4196116 |
87 | WO publication number | WPN | 2022038038 |
54 | Designation/title | TI | PHARMAZEUTISCHE ZUSAMMENSETZUNG, UMFASSEND CABOZANTINIB, PLERIXAFOR, AFATINIB UND ETORICOXIB ZUR VERWENDUNG BEI DER BEHANDLUNG ODER PROPHYLAXE VON NSCLC OHNE DRIVERMUTATIONEN |
51 | IPC main class | ICM (ICMV) | A61K 31/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/444 (2006.01), A61K 31/47 (2006.01), A61K 31/517 (2006.01), A61K 45/06 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Aug 12, 2021 |
96 | EP application date | EAT | Aug 12, 2021 |
86 | WO application date | WAT | Aug 12, 2021 |
43 | Date of first publication | OT | Feb 24, 2022 |
| Date of publication of grant | PET | Jul 10, 2024 |
71/73 | Applicant/owner | INH | EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH, 13125 Berlin, DE; Langhammer, Stefan, 30938 Burgwedel, DE |
72 | Inventor | IN | HOFFMANN, Jens, 13125 Berlin, DE; GÜRGEN, Dennis, 13409 Berlin, DE; LANGHAMMER, STEFAN, Dr., 30938 Burgwedel, DE |
74 | Representative | VTR | Prinz & Partner mbB, 10117 Berlin, DE |
66 66
| Domestic priority | PRN PRD
| 10 2020 005 002.6 Aug 17, 2020
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Member states EPGÜ | EPGUE | AT, BE, BG, DE, DK, EE, FI, FR, IT, LT, LU, LV, MT, NL, PT, SE, SI |
| Published EP/WO documents | EPWOPN | Original document:
EP000004196116A2 Searchable text:
EP000004196116A2 Original document:
EP000004196116B1 Searchable text:
EP000004196116B1 Original document:
WO002022038038 Searchable text:
WO002022038038 |
43 | Date of first publication | EVT | Feb 24, 2022 |
| Date of the first transfer into DPMAregister | EREGT | Jun 21, 2023 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2025 (Show all update days)(Hide all update days)- May 8, 2025
- Type of IP right: changed
- File number displayed in the result list: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 10.07.2024: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 10.07.2024: deleted
- Oct 10, 2024
- Procedures: EP procedure, EP patent – unitary effect effective, 10.07.2024: changed
- Procedures: EP procedure, EP patent – unitary effect registered, 23.08.2024: changed
- Sep 5, 2024
- Representative: new
- Address for service: deleted
- Due date: deleted
- Member states EPGÜ: new
- Procedures: EP procedure, EP patent – unitary effect effective, 10.07.2024: new
- Procedures: EP procedure, EP patent – unitary effect registered, 23.08.2024: new
- Aug 15, 2024
- Procedures: EP procedure, EP patent – request for unitary effect, 30.07.2024: new
- Aug 1, 2024
- Procedures: Publications, DPMA mention of EP grant, 01.08.2024: new
- Jun 25, 2024; Jun 20, 2024; May 16, 2024; Mar 21, 2024
- Historical data not available for this/these date(s)
- Jun 21, 2023
- Date of the first transfer into DPMAregister
|